Pfizer Inc. elected COO Albert Bourla to its board, effective Feb. 23.
Prior to his appointment as COO, Bourla was the group president of Pfizer Innovative Health.
Pfizer adds COO to board
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021
Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective
Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective
Pfizer adds COO to board
- Author Angelee Tabios
- Theme Healthcare & Pharmaceuticals
- Author
- Angelee Tabios
- Theme
- Healthcare & Pharmaceuticals